Product Profile

Paracetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate Oral Drops are a precision-dosed pediatric cold and fever formulation — delivering antipyretic relief, nasal decongestion, and antihistamine action in a concentrated liquid format specifically designed for children aged 2 to 5 years. As a WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech manufactures these drops with validated three-active assay control, calibrated dropper precision, and premium 15ml packaging for third-party manufacturing, contract manufacturing, and private-label pediatric cold brand supply.

Manufacturing Advantage

Why Saar Biotech for Paracetamol + Phenylephrine + CPM Drops?

Since {{ site.Params.founded }}, Saar Biotech has been a distinguished WHO-GMP certified leader in pharmaceutical manufacturing. We utilize advanced micronization and pH-stabilization protocols to deliver unmatched bioavailability for this Paracetamol + Phenylephrine + CPM Drops formulation.

DCGI Approved

Comprehensive documentation and CDSCO support for rapid market entry in India.

Fast Turnaround

30-45 days lead time for new batches with state-of-the-art logistics.

Pan-India Supply & Contract Manufacturing

Batch Lead Time 30-45 Days (Domestic)
B2B Services Contract & Third-Party
Compliance DCGI & Schedule M Standards
Medical Intelligence

Clinical Q&A for Paracetamol + Phenylephrine + CPM Drops

Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.

What are the clinical indications for Paracetamol 125mg + Phenylephrine 2.5mg + CPM 1mg Oral Drops?

These pediatric oral drops are indicated for the symptomatic relief of common cold, fever, nasal congestion, runny nose, sneezing, and body aches in children aged 2 to 5 years. The combination provides multi-symptom relief — Paracetamol addresses fever and pain, Phenylephrine acts as a nasal decongestant, and Chlorpheniramine Maleate provides antihistamine action against allergic symptoms. Clinical studies have demonstrated that this fixed-dose combination is efficacious and well-tolerated for treating common cold in children.

How does this three-component combination work in children?

Paracetamol acts centrally in the hypothalamic thermoregulatory centre to reduce fever and provides analgesic action through inhibition of prostaglandin synthesis. Phenylephrine HCl is a selective alpha-1 adrenergic agonist that causes vasoconstriction in the nasal mucosa, reducing mucosal oedema and relieving nasal congestion. Chlorpheniramine Maleate is a first-generation H1 antihistamine that competitively blocks histamine receptors, reducing rhinorrhea, sneezing, and watery eyes — the allergic symptoms that often accompany colds.

What is the standard dosing protocol for these drops?

The standard pediatric dose is 1 ml (delivering Paracetamol 125mg + Phenylephrine 2.5mg + CPM 1mg) administered every 4 to 6 hours, up to a maximum of 4 doses in 24 hours. The drops should be administered directly into the child’s mouth using the calibrated dropper, or mixed with a small amount of water or milk. Dosing should be based on the child’s weight and age, and should always follow the prescribing physician’s instructions.

What is the clinical evidence for this pediatric formulation?

A post-marketing surveillance study evaluated this fixed-dose combination (Paracetamol 125mg + Phenylephrine 2.5mg + CPM 1mg per ml) in 200 children with common cold symptoms. Complete remission was achieved in 82% of patients, with statistically significant reductions in symptom severity scores from day 1 to day 5. No adverse events were observed, and 92.5% of parents and 97.5% of investigators rated the treatment as good to excellent.

What are the key contraindications and precautions?

These drops are contraindicated in patients with known hypersensitivity to any component. Paracetamol should be used with caution in patients with hepatic impairment. Phenylephrine should be avoided in patients with severe hypertension, cardiovascular disease, or those taking MAO inhibitors. CPM should be used with caution in patients with narrow-angle glaucoma, urinary retention, or prostatic hypertrophy. Use in children under 2 years should be under strict physician supervision.
Manufacturing Support

B2B Manufacturing Guide for Paracetamol + Phenylephrine + CPM Drops

Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.

What pack sizes and packaging options are available for contract manufacturing?
Saar Biotech manufactures these pediatric drops exclusively in the 15ml format — the established commercial standard for pediatric oral drops in India. Packaging options include: 15ml PET amber bottle with calibrated dropper and mono-carton, drip-off brand embossed carton with sticker label and dropper, normal label with drip-off carton and dropper, printed cap plus dropper, and 360×15ml shipper configurations for high-volume distributor dispatch.
What is the MOQ for these pediatric drops?
For this category, the standard MOQ is accessible at 5,000 to 10,000 units. These pediatric cold drops are a year-round prescribed product — peaking in monsoon and winter respiratory seasons. Our automated 15ml filling lines in Baddi support rapid scale-up from brand-entry volumes to 2,00,000+ unit commercial runs.
What flavour options are available for these pediatric drops?
Mix-fruit is the primary and most commercially accepted flavour for pediatric cold drops in this format. It effectively masks the bitter CPM note and mild astringency of Phenylephrine while remaining familiar and non-offensive to infants and toddlers. Custom flavour profiles can be evaluated during development.
What analytical tests are performed on every batch?
Every batch undergoes HPLC Assay confirming Paracetamol 125mg, Phenylephrine HCl 2.5mg, and CPM 1mg per 1ml against IP specifications. pH and viscosity testing ensures the drops base remains stable and flows correctly through the calibrated dropper. Uniformity of dose testing confirms consistent active distribution throughout the 15ml fill volume. Microbial Limit Testing meets IP specifications for oral liquid products. A Certificate of Analysis accompanies every B2B consignment.
What is the turnaround time for a new drops order?
Standard turnaround for a fresh product launch is 30 to 45 days after final artwork sign-off. Returning B2B clients benefit from an accelerated 20 to 25-day delivery schedule for re-orders.
Call Us
WhatsApp
Email